| Literature DB >> 31396092 |
Grant W Ralston1, Lon Kilgore2, Frank B Wyatt3, Frédéric Dutheil4,5, Patrick Jaekel6,7, Duncan S Buchan1, Julien S Baker1.
Abstract
Background: Recommendations on resistance training (RT) set-volume protocols in preparation for spaceflight muscular strength conditioning remains equivocal. A meta-analysis was performed on the effects of single-set (S), or three-set (M3) RT on muscular strength per exercise for different body segments and joint types (multi-joint and single-joint).Entities:
Keywords: one vs.multiple-sets and muscular strength; one vs.three-sets and muscular strength; resistance training and muscular strength; resistance training and training volume; single vs.multiple-sets
Year: 2019 PMID: 31396092 PMCID: PMC6668575 DOI: 10.3389/fphys.2019.00864
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Summary of previous meta-analyses on set-volume and strength development.
| Rhea et al., | Identify a dose-response relationship for intensity, frequency, and volume of training | MJ and SJ comb | Untrained and trained subjects should perform four-sets per muscle group. |
| Peterson et al., | MJ and SJ comb | Athletes should perform eight-sets per muscle group for athletes. | |
| Peterson et al., | Review of recent evidence on strength development research | MJ and SJ comb | Untrained subjects should perform four-sets per muscle group. Trained subjects should perform eight-sets per muscle group. |
| Wolfe et al., | Examination of single-set vs. multiple-set on muscle strength | MJ and SJ comb | MS (two-five sets) elicit superior strength gains for trained subjects. Untrained subjects should perform S initially. |
| Krieger, | Comparison of the effects S-vs.-MS per exercise have on strength | MJ and SJ comb | Maximal strength gains are elicited with two-three-sets per exercise than S, in both untrained and untrained subjects. |
| Fröhlich et al., | Comparison of the effects of S-vs.-MS for increasing maximal strength levels | MJ and SJ comb | S regimes are equivalent to MS training for increasing strength in the initial period. MS training is superior overextended periods. |
N, number; MJ, multi-joint; SJ, single-joint; comb, combined; MS, multiple-sets; S, single-joint.
Figure 1The flow of journal articles through the systematic review process.
Inclusion and exclusion criteria.
| One or more muscle groups used duration intervention and appropriate strength assessment (i.e., single-joint exercises, e.g., leg curl) | Small subject sample groups (e.g., |
| The minimum duration of the training intervention is 4-weeks; preferably longitudinal studies (>12-weeks) | The use of either legal or illegal ergogenic aids or supplementation prior to or during interventions |
| It would be desirable if there were an appropriate control group included within the research design with subjects randomly assigned to groups | Training order variation throughout the intervention |
| Training programme supervised throughout the intervention. Ensuring that interventions are of similar order and if applicable inter-set recovery periods standardized for multiple-sets | No quasi RCT or narrative studies/reviews to be included |
| The warm-up is standardized between treatment groups | Subjects below 18 or above 45 years of age |
| Appropriate criteria were specified regarding training loading (intensity) and subjects trained to volitional fatigue | Researchers did not report results adequately (pre-to-post-mean and standard deviation) |
| Subject groups comparing 1- vs. 3-sets per exercise per session | Investigated the effects of nutritional supplements in combination with resistance training |
| Subjects used resistance training as a means of training | Concurrent aerobic and strength training interventions |
| Studies published in the English language journals only |
Characteristics of excluded studies investigating 1-vs. 3-sets.
| Kraemer, | RAN | T | M | 40 | 20± 2.3 | 3 | 12 | 1/3 | 8–12 | 1RM BP, 1RM LP | Excluded due to differences between groups, single circuit group performed forced reps at the end, and multiple circuit group did no forced reps |
| Borst et al., | CT | U | C | 31 | 37± 7 | 3 | 25 | 1/3 | 8–12 | Sum of 1RM for CP and LExt | Excluded due to inadequate evidence of pre-and post-intervention training means and SDs to calculate an effect size |
| McBride et al., | RCT | U | C | 28 | 21.52± 1.3 | 2 | 12 | 1/3 | 6–15 | 1RM LP; 1RM BC | Excluded due to amount of sets subjects were performing |
| Galvão and Taaffe, | RAN | U | C | 28 | 65–78 | 2 | 20 | 1/3 | 8 | Maximum isokinetic and isometric KExt strength | Excluded due to subjects age range |
| Munn et al., | RCT | U | C | 115 | 20.6 ± 6.1 | 3 | 6 | 1/3 | 6–8 | 1RM EFlex | Excluded due to the primary aim, which was the effects of contraction speed with one or three-sets at fast or slow speeds |
| Rønnestad et al., | RAN | U | M | 21 | 26.6± 0.1 | 3 | 11 | 1/3 | 7–10 | 1RM lower body (LP, LExt, LC); 1RM upper body (CP, Row, LatP, BC, SP) | Provided the subjects with nutritional supplementation (protein chocolate bar) and energy drinks during each exercise bout |
| Starkey et al., | RCT | U | C | 48 | 18–50 | 3 | 14 | 1/3 | 8–12 | Maximal isometric KFlex; KExt | Study data identified as an outlier when observed using the Galbraith plot |
N, number; y, years; SD, standard deviation; wk, weeks; Reps, repetitions; RAN, randomly assigned trial; T, trained; M, male; 1RM, 1 repetition maximum; BP, bench press; LP, leg press; CT, control trial; U, untrained; C, male and female subjects combined; CP, chest press; LExt, leg extension; SD, standard deviation; RCT, randomized controlled trial; BC, bicep curl; KExt, knee extensor; EFlex, elbow flexor; LC, leg curl; Row, seated row; LatP, latissimus pull-down; SP, shoulder press; KFlex, knee flexion.
Study and subject characteristics 1-vs. 3-sets.
| Hass et al., | RAN | T | C | 42 | 39.2–40.1 | Yes | 3 | 13 | 1/3 | 8–12 | 67–80 | [1RM] LExt, LC, CP, OP, BC |
| Rhea et al., | RAN | T | M | 16 | 20–22 | Yes | 3 | 12 | 1/3 | 8–12 | 67–80 | [1RM] BP, LP |
| Paulsen et al., | RAN | U | M | 18 | 20–30 | Yes | 3 | 6 | 1/3 | 7 | 83 | [1RM] Sq, KExt, LC, BP, SP, Row, LatP |
| Kelly et al., | RCT | T | C | 40 | 22.2–25.3 | Max effort | 2 | 8 | 1/3 | 8 | 80 | [Nm] KExt |
| Bottaro et al., | RAN | U | M | 24 | 19–25.4 | Yes | 2 | 12 | 1/3 | 8–12 | 67–80 | [1RM] KExt, EExt |
| Baker et al., | RAN | T | M | 16 | 18–21 | Yes | 3 | 8 | 1/3 | 6 | 85 | [1RM and Nm] BP, SP, BC |
| Sooneste et al., | RAN | U | M | 8 | 22.9–27.1 | Yes | 2 | 12 | 1/3 | 8 | 80 | [1RM] SPC |
| Reid et al., | RAN | U | M | 34 | 18–35 | Yes | 3 | 8 | 1/2/3 | 3–18 | 63–93 | [1RM] EFlex, EExt, KFlex, KExt, SFlex, SExt |
| Kramer et al., | RAN | T | M | 43 | 20.3 ± 1.9 [SEM] | Yes | 3 | 14 | 1/3 | 8–12 | 67–80 | [1RM] Sq |
| Schlumberger et al., | RCT | T | F | 27 | 20–40 | Yes | 2 | 6 | 1/3 | 6–9 | 65–77 | [1RM] LExt, BP |
| Humburg et al., | RCT | U | C | 29 | 23.1–27.1 | Yes | 3 | 9 | 1/3 | 8–12 | 67–80 | [1RM] BC, LP, BP |
| Radaelli et al., | RCT | U | M | 48 | 23.5–25.3 | Yes | 3 | 26 | 1/3/5 | 8–12 | 67–80 | [5RM] BP, LP, LatP, SP |
| Total/mean ± SD | 393 | 2.7 (± 0.49) | 11.2 (± 5.4) | 9.0 (± 1.7) | 76.5 (± 7.5) |
N, number; y, years; SD, standard deviation; wk, weeks; Reps, repetitions; % 1RM, percentage of subjects one repetition maximum; RAN, randomly assigned trial; T, trained; C, male and female subjects combined; 1RM, 1 repetition maximum; LExt, leg extension; LC, leg curl; CP, chest press; OP, overhead press; BC, bicep curl; M, male; BP, bench press; LP, leg press; U, untrained; SEM, standard error of measurement; Sq, squat; KExt, knee extension; SP, shoulder press; Row, seated row; LatP, latissimus pull-down; RCT, randomized controlled trial; Nm, peak torque; 5RM, subjects five repetition maximum; EFlex, elbow flexion; KFlex, knee flexion; SFlex, shoulder flexion; SExt, shoulder extension; SPC, seated preacher curl; F, female.
Resistance training characteristics and weekly training volume.
| Hass et al., | LExt, LC, PullO, ACross, CP, LatR, OP, BC, TriExt | S:3 | S: 8–12 | S:24–36 | S = 216–324 |
| Rhea et al., | BP, LP. S performed additional exercises BC, LatP, AbC, BExt, Row | S:3 | S: 8–12 | S:24–36 | S = 168–252 |
| Paulsen et al., | Sq, KExt, LC, BP, SP, Row, LatP | S:3 | S: 7 | S:21 | S = 147 |
| Kelly et al., | KExt | S:2 | S: 8 | S:16 | S = 16 |
| Bottaro et al., | LP, PullO, KFlex, CP, BC, AbC | S:2 | S: 8–12 | S:16–24 | S = 96–144 |
| Baker et al., | BP, IncBP, DumF, BCbar, BCdumb, HammerC, SP, LatR, URow | S:3 | S: 6 | S: 18 | S = 162 |
| Sooneste et al., | SPC | S:2 | S: 8 | S:16 | S = 16 |
| Reid et al., | LExt, LC, LP, CR, BP, MilPres, LatP, TriExt, BC | S:3 | S: 8 | S:24 | S = 216 |
| Kramer et al., | Sq, PushP, BP, AbC, PullTh, LC, BRow | S:3 | S: 8–12 | S:24–36 | S = 168–252 |
| Schlumberger et al., | LExt, LC, AbC, ShAdd, ShAbd, BP, LatP | S:2 | S: 6–9 | S:12–18 | S = 84–126 |
| Humburg et al., | BC, LP, BP | S:3 | S: 8–12 | S:24–36 | S = 72–108 |
| Radaelli et al., | BP, LP, LatP, LExt, SP, LC, BC, AbC, TriExt | S:3 | S: 8–12 | S:24–36 | S = 216–324 |
RT, resistance training; LExt, leg extension; LC, leg curl; PullO, pull-over; ACross, arm cross-over; CP, chest press; LatR, lateral raise; OP, overhead press; BC, bicep curl; TriExt, tricep extension; BP, bench press; S, one-set; M3, three-sets; LP, leg press; LatP, latissimus pull-down; AbC, abdominal curl; BExt, back extension; Row, seated row; Sq, squat; KExt, knee extension; SP, shoulder press; KFlex, knee flexion; IncBP, incline bench press; DumF, dumbbell flye; BCbar, bicep curl with bar; BCdumb, bicep curl with dumbbells; HammerC, hammer curl; URow, upright row; SPC, seated preacher curl; MilPres, military press; PushP, push press; PullTh, pull through; Brow, back row; SHadd, shoulder adduction; ShAbd, shoulder abduction.
Methodological quality of studies based on the PEDro score.
| Reid et al., | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Kramer et al., | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Hass et al., | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Schlumberger et al., | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Rhea et al., | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |
| Paulsen et al., | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Humburg et al., | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Kelly et al., | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 5 |
| Bottaro et al., | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Baker et al., | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Sooneste et al., | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Radaelli et al., | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
PEDro, Physiotherapy Evidence Database. The PEDro scale is based on the Delphi list (Verhagen, :
= eligibility criteria (1a = eligibility criteria specified [1 = yes/0 = no]), 2 = random allocation, 3 = concealed allocation, 4 = groups similar at baseline, 5 = blinded subjects, 6 = blinded therapists, 7 = blinded assessors, 8 = follow-up measures obtained for > 85% of subjects, 9 = intention to treat analysis, 10 = between groups statistical comparison, 11 = point measures and measures of variability.
Figure 2Galbraith plot used to examine study heterogeneity (pre- vs. post-strength change). Each open circle represents one pre- vs. post-study data.
Pre- vs. post-strength analysis of multi-joint exercise.
| Hass et al., | 42 | S:21 | 39.2–40.1 | 3 per wk | CP | 1 (8–12) | 8–12RM | S | 1.9 ± 0.6 vs. 2.1 ± 0.5 | 10.5 | ≤0.05 | 0.36 |
| M3:21 | CP | 3 (8–12) | M3 | 2.1 ± 0.7 vs. 2.3 ± 0.6 | 9.5 | ≤0.05 | 0.31 | |||||
| Hass et al., | 42 | S:21 | 39.2–40.1 | 3 per wk | OP | 1 (8–12) | 8–12RM | S | 1.9 ± 0.4 vs. 2.0 ± 0.4 | 5.3 | ≤0.05 | 0.25 |
| M3:21 | OP | 3 (8–12) | M3 | 2.0 ± 0.6 vs. 2.3 ± 0.6 | 15.0 | ≤0.05 | 0.5 | |||||
| Rhea et al., | 16 | S:8 | 19–23 | 3 per wk | LP | 1 (8–12) | 8–12RM | S | 269.0 ± 16.8 vs. 337.2 ± 69.0 | 25.4 | ≤0.05 | 1.36 |
| M3:8 | LP | 3 (8–12) | M3 | 225.9 ± 25 vs. 343.5 ± 89.9 | 52.1 | ≤0.05 | 1.78 | |||||
| Rhea et al., | 16 | S:8 | 19–23 | 3 per wk | BP | 1 (8–12) | 8–12RM | S | 64.2 ± 8.9 vs. 76.7 ± 28.0 | 19.5 | ≤0.05 | 0.60 |
| M3:8 | BP | 3 (8–12) | M3 | 66.8 ± 7.3 vs. 85.5 ± 20.8 | 28 | ≤0.05 | 1.20 | |||||
| Paulsen et al., | 18 | S:10 | 20–30 | 3 per wk | Sq | 1 (7) | 7RM | S | 129.5 ± 65.1 vs. 147 ± 67.4 | 13.5 | ≤0.01 | 0.26 |
| M3:8 | Sq | 3 (7) | M3 | 122.5 ± 82.0 vs. 149.4 ± 82 | 22.0 | ≤0.01 | 0.33 | |||||
| Paulsen et al., | 18 | S:10 | 20–30 | 3 per wk | BP | 1 (7) | 7RM | S | 74.8 ± 22.1 vs. 82.3 ± 26.3 | 10 | ≤0.01 | 0.31 |
| M3:8 | BP | 3 (7) | M3 | 77.8 ± 32 vs. 85.0 ± 36.5 | 9.3 | ≤0.01 | 0.21 | |||||
| Baker et al., | 16 | S:8 | 18–21 | 3 per wk | BP | 1 (6) | 6RM | S | 659.4 ± 112.7 vs. 776.2 ± 121.5 | 17.7 | ≤0.05 one tailed | 1.00 |
| M3:8 | BP | 3 (6) | M3 | 671.3 ± 131.3 vs. 789.9 ± 96.0 | 17.7 | ≤0.05 one tailed | 1.03 | |||||
| Baker et al., | 16 | S:8 | 18–21 | 3 per wk | SP | 1 (6) | 6RM | S | 412.6 ± 71.5 vs. 527.2 ± 74.5 | 27.8 | ≤0.05 one tailed | 1.57 |
| M3:8 | SP | 3 (6) | M3 | 418.5 ± 49.0 vs. 510.6 ± 62.7 | 22.0 | ≤0.05 one tailed | 1.64 | |||||
| Kramer et al., | 43 | S:16 | 20.3 ± 1.9 [SEM] | 3 per wk | Sq | 1 (8–12) | 8–12RM | S | 101.9 ± 20.6 vs. 114.1 ± 18.7 | 12.0 | / | 0.62 |
| M3:14 | Sq | 3 (8–12) | M3 | 98.5 ± 27.7 vs. 123.7 ± 43.2 | 25.6 | ≤0.05 | 0.69 | |||||
| MSV3: 13 | Sq | 1–3(3–10) | MSV3 | 111.2 ± 25.6 vs. 135.7 ± 20.6 | 22.03 | ≤0.05 | 1.05 | |||||
| Schlumberger et al., | 27 | Con: 9 | 20–40 | 2 per wk | BP | Con (0) | 6RM | Con | 28.1 ± 2.4 vs. 27.2 ± 2.9 | 3.2 | / | −0.34 |
| S:9 | BP | 1 (6–9) | S | 31.7 ± 9.0 vs. 33.0 ± 9.3 | 4.1 | 0.14 | ||||||
| M3:9 | BP | 3 (6–9) | M3 | 26.9 ± 3.5 vs. 29.7 ± 4.6 | 10.4 | ≤0.05 | 0.69 | |||||
| Humburg et al., | 29 | Con: 7 | 23.1–27.1 | 3 per wk | BP | Con (0) | 8–12RM | Con | 47.5 ± 15.7 vs. 48.2 ± 17.1 | 1.47 | / | 0.04 |
| S: 22 | BP | 1 (8–12) | S | 56.1± 20.6 vs. 61.7 ± 21.7 | 10.0 | ≤0.05 | 0.26 | |||||
| M3: 22 | BP | 3 (8–12) | M3 | 54.9 ± 21.6 vs. 63.0 ± 23.0 | 14.8 | ≤0.05 | 0.36 | |||||
| Humburg et al., | 29 | Con: 7 | 23.1–27.1 | 3 per wk | LP right leg | Con (0) | 8–12RM | Con | 155.7 ± 23.1 vs. 149.8 ± 26.2 | −3.80 | / | −0.24 |
| S: 22 | LP right leg | 1 (8–12) | S | 174.4 ± 44.7 vs. 188.1 ± 36.4 | 7.9 | ≤0.05 | 0.34 | |||||
| M3: 22 | LP right leg | 3 (8–12) | M3 | 172.7 ± 38.4 vs. 195.3 ± 44.7 | 13.1 | ≤0.05 | 0.54 | |||||
| Humburg et al., | 29 | Con: 7 | 23.1–27.1 | 3 per wk | LP left leg | Con (0) | 8–12RM | Con | 156.5 ± 31.5 vs. 149.7 ± 33.8 | −4.35 | / | −0.21 |
| S: 22 | LP left leg | 1 (8–12) | S | 169.5 ± 40.2 vs. 183.1± 36.1 | 8.0 | ≤0.05 | 0.36 | |||||
| M3: 22 | LP left leg | 3 (8–12) | M3 | 165.4 ± 38.2 vs. 189.9 ± 44.9 | 14.8 | ≤0.05 | 0.59 | |||||
| Radaelli et al., | 48 | Con: 10 | 23.5–25.3 | 3 per wk | BP | Con (0) | 8–12RM | Con | 68.3 ± 11.4 vs. 64.4 ± 8.8 | −5.71 | / | −0.38 |
| S:12 | BP | 1 (8–12) | S | 64.5 ± 9.5 vs. 73.2 ± 9.9 | 13.5 | ≤0.05 | 0.90 | |||||
| M3:13 | BP | 3 (8–12) | M3 | 73.4 ± 9.4 vs. 86.1 ± 8.4 | 17.3 | ≤0.05 | 1.42 | |||||
| M5:13 | BP | 5 (8–12) | M5 | 89.6 ± 9.6 vs. 99.6 ± 5.5 | 11.2 | ≤0.05 | 1.13 | |||||
| Radaelli et al., | 48 | Con: 10 | 23.5–25.3 | 3 per wk | LatP | Con (0) | 8–12RM | Con | 60.5 ± 6.8 vs. 62.2 ± 6.6 | 2.8 | / | 0.25 |
| S:12 | LatP | 1 (8–12) | S | 57.9 ± 10.7 vs. 68.7 ± 9.5 | 18.7 | ≤0.05 | 1.07 | |||||
| M3:13 | LatP | 3 (8–12) | M3 | 62.5 ± 6.21 vs. 70.0 ± 4.76 | 12.0 | ≤0.05 | 1.36 | |||||
| M5:13 | LatP | 5 (8–12) | M5 | 74.2 ± 9.5 vs. 86.5 ± 6.5 | 16.6 | ≤0.05 | 1.51 | |||||
| Radaelli et al., | 48 | Con: 10 | 23.5–25.3 | 3 per wk | SP | Con (0) | 8–12RM | Con | 26.1 ± 7.4 vs. 29.4 ± 7.6 | 12.6 | – | 0.44 |
| S:12 | SP | 1 (8–12) | S | 31.6 ± 7.1 vs. 38.7 ± 9.3 | 22.5 | ≤0.05 | 0.86 | |||||
| M3:13 | SP | 3 (8–12) | M3 | 34.2 ± 7.5 vs. 42.3 ± 6.3 | 23.7 | ≤0.05 | 1.17 | |||||
| M5:13 | SP | 5 (8–12) | M5 | 41.5 ± 8.2 vs. 56.1 ± 11.9 | 35.2 | ≤0.05 | 1.43 | |||||
| Radaelli et al., | 48 | Con: 10 | 23.5–25.3 | 3 per wk | LP | Con (0) | 8–12RM | Con | 157.8 ± 21.0 vs. 155.0 ± 25.0 | −1.8 | / | −0.12 |
| S:12 | LP | 1 (8–12) | S | 170 ± 34.1 vs. 196.7 ± 15.5 | 15.7 | ≤0.05 | 1.01 | |||||
| M3:13 | LP | 3 (8–12) | M3 | 172.5 ± 30.1 vs. 199.2 ± 14.4 | 15.5 | ≤0.05 | 1.13 | |||||
| M5:13 | LP | 5 (8–12) | M5 | 178.5 ± 24.4 vs. 201.5 ± 25.4 | 12.9 | ≤0.05 | 0.92 |
N, number of subjects; y, years; SD, standard deviation; Reps, repetitions; ES, effect size; S, one-set; M3 three-sets; LP, leg press; RM, repetition maximum; BP, bench press; Sq, squat; SP, shoulder press; MSV3, multiple-sets with changes in training volume; Con, control group; LatP, lateral pull-down; SP, shoulder press; CP, chest press; OP, overhead press.
Significantly greater than prior to training (P ≤ 0.05).
Significant differences from corresponding groups-exercise values (P ≤ 0.05).
Significantly greater prior to training (P ≤ 0.01).
Pre- vs. post-strength analysis on single-joint exercise.
| Hass et al., | 42 | S:21 | 39.2–40.1 | 3 per wk | LExt | 1 (8-12) | 8–12RM | S | 2.4 ± 0.4 vs. 2.7 ± 0.4 | 12.5 | ≤0.05 | 0.75 |
| M3:21 | LExt | 3 (8–12) | M3 | 2.6 ± 0.4 vs. 2.9 ± 0.4 | 11.5 | ≤0.05 | 0.75 | |||||
| Hass et al., | 42 | S:21 | 39.2–40.1 | 3 per wk | LCurl | 1 (8–12) | 8–12RM | S | 2.0 ± 0.3 vs. 2.1 ± 0.2 | 5 | ≤0.05 | 0.39 |
| M3:21 | LCurl | 3 (8–12) | M3 | 2.1± 0.2 vs. 2.3 ± 0.2 | 9.5 | ≤0.05 | 1.00 | |||||
| Hass et al., | 42 | S:21 | 39.2–40.1 | 3 per wk | BC | 1 (8–12) | 8–12RM | S | 1.0 ± 0.3 vs. 1.1 ± 0.3 | 10 | ≤0.05 | 0.33 |
| M3:21 | BC | 3 (8–12) | M3 | 1.1± 0.3 vs. 1.2 ± 0.3 | 9.1 | ≤0.05 | 0.33 | |||||
| Paulsen et al., | 18 | S:10 | 20–30 | 3 per wk | KExt | 1 (7) | 7RM | S | 125.8 ± 52.8 vs. 144 ± 45.5 | 14.5 | ≤0.01 | 0.37 |
| M3:8 | KExt | 3 (7) | M3 | 117.8 ± 38.2 vs. 142.5 ± 25.2 | 21.0 | ≤0.01 | 0.76 | |||||
| Paulsen et al., | 18 | S:10 | 20–30 | 3 per wk | LCurl | 1 (7) | 7RM | S | 57.3 ± 30.4 vs. 64.8 ± 24.03 | 13.1 | ≤0.01 | 0.27 |
| M3:8 | LCurl | 3 (7) | M3 | 55.9 ± 29.1 vs. 65.3 ± 37.1 | 16.8 | ≤0.01 | 0.25 | |||||
| Kelly et al., | 40 | Con: 8 | 22.2–25.3 | 2 per wk | Con | Con (0) | 8RM | Con | 135.7 ± 77.1 vs. 127.1 ± 64.6 | 6.3 | / | −0.12 |
| S:14 | KExt | 1 (8) | S | 163.5 ± 56.4 vs. 171.2 ± 70 | 4.7 | ≤0.05 | 0.12 | |||||
| M3:18 | KExt | 3 (8) | M3 | 171.4 ± 62.0 vs. 200.8 ± 111.1 | 17.2 | ≤0.05 | 0.33 | |||||
| Bottaro et al., | 24 | S:13 | 22.2 ± 3.2 | 2 per wk | KExt | 1 (8–12) | 8–12RM | S | 24.3 ± 3.0 vs. 25.3 ± 2.9 | 4.1 | ? | 0.34 |
| M3:11 | KExt | 3 (8–12) | M3 | 20.9 ± 3.2 vs. 23.4 ± 2.3 | 12.0 | ≤0.05 | 0.90 | |||||
| Bottaro et al., | 24 | S:13 | 22.2 ± 3.2 | 2 per wk | EExt | 1 (8–12) | 8–12RM | S | 51.4 ± 10.9 vs. 55.2 ± 10.2 | 7.4 | ≤0.05 | 0.36 |
| M3:11 | EExt | 3 (8–12) | M3 | 45.6 ± 5.9 vs. 48.3 ± 8.2 | 5.9 | ≤0.05 | 0.38 | |||||
| Baker et al., | 16 | S:8 | 18–21 | 3 per wk | BC | 1 (6) | 6RM | S | 402.8 ± 54.8 vs. 485.1 ± 48 | 20.4 | ≤0.05 one tailed | 1.60 |
| M3:8 | BC | 3 (6) | M3 | 421.4 ± 44.1 vs. 499.8 ± 77.4 | 18.6 | ≤0.05 one tailed | 1.24 | |||||
| Sooneste et al., | 8 | S:8 | 25.0 ± 2.1 | 2 per wk | SPC | 1 (8) | 8RM | S | 9.1 ± 1.6 vs. 10.9 ± 2.5 | 19.8 | ≤0.05 | 0.86 |
| M3:8 | SPC | 3 (8) | M3 | 9.1 ± 1.6 vs. 11.9 ± 2.9 | 30.8 | ≤0.05 | 1.20 | |||||
| Reid et al., | 34 | S:9 | 18–35 | 3 per wk | KFlex | 1 (10–12) | 6–12RM | S | 34.2 ± 6.4 vs. 39.7 ± 8 | 16.1 | ≤0.05 | 0.76 |
| M3:9 | KFlex | 3 (6) | M3 | 35.2 ± 5.3 vs. 40 ± 5.6 | 13.6 | ≤0.01 | 0.88 | |||||
| Reid et al., | 34 | S:9 | 18–35 | 3 per wk | KExt | 1 (10–12) | 6–12RM | S | 80.5 ± 15.8 vs. 95.5 ± 17.8 | 18.6 | ≤0.01 | 0.89 |
| M3:9 | KExt | 3 (6) | M3 | 90.0 ± 16.7 vs. 103.6 ± 16.4 | 15.1 | ≤0.01 | 0.82 | |||||
| Reid et al., | 34 | S:9 | 18–35 | 3 per wk | EFlex | 1 (10–12) | 6–12RM | S | 39.3 ± 4.2 vs. 43.9 ± 6.3 | 11.7 | ≤0.01 | 0.86 |
| M3:9 | EFlex | 3 (6) | M3 | 42 ± 5.2 vs. 45.5 ± 6.9 | 8.3 | ≤0.05 | 0.57 | |||||
| Reid et al., | 34 | S:9 | 18–35 | 3 per wk | EExt | 1 (10–12) | 6–12RM | S | 28.5 ± 7 vs. 35 ± 10.8 | 22.8 | ≤0.01 | 0.71 |
| M3:9 | EExt | 3 (6) | M3 | 33.4 ± 8.1 vs. 40.3 ± 10.3 | 20.7 | ? | 0.74 | |||||
| Reid et al., | 34 | S:9 | 18–35 | 3 per wk | SFlex | 1 (10–12) | 6–12RM | S | 47.3 ± 10.7 vs. 58.3 ± 10.7 | 23.3 | ≤0.01 | 1.03 |
| M3:9 | SFlex | 3 (6) | M3 | 52.9 ± 11.9 vs. 64.4 ± 9.8 | 21.7 | ≤0.05 | 1.05 | |||||
| Reid et al., | 34 | S:9 | 18–35 | 3 per wk | SExt | 1 (10–12) | 6–12RM | S | 48.2 ± 11.1 vs. 54.8 ± 11.2 | 13.7 | ? | 0.59 |
| M3:9 | SExt | 3 (6) | M3 | 51.8 ± 9.1 vs. 66.5 ± 11.1 | 28.4 | ≤0.01 | 1.44 | |||||
| Schlumberger et al., | 27 | Con: 9 | 20–40 | 2 per wk | LExt | Con (0) | 6RM | Con | 44.1 ± 7.7 vs. 44.0 ± 8.6 | −0.23 | / | −0.01 |
| S:9 | LExt | 1 (6–9) | S | 44.8 ± 6.8 vs. 47.8 ± 7.9 | 6.7 | ≤0.05 | 0.41 | |||||
| M3:9 | LExt | 3 (6–9) | M3 | 43.7 ± 6.1 vs. 50.6 ± 7.6 | 15.8 | ≤0.05 | 1.00 | |||||
| Humburg et al., | 29 | Con: 7 | 23.1–27.1 | 3 per wk | BC | Con (0) | 8–12RM | Con | 25.9 ± 11.9 vs. 25.6 ± 12.1 | −1.2 | / | −0.02 |
| S: 22 | BC | 1 (8–12) | S | 28.1 ± 9.4 vs. 30.0 ± 9.4 | 6.8 | ≤0.05 | 0.20 | |||||
| M3: 22 | BC | 3 (8-12) | M3 | 26.4 ± 9.5 vs. 30.6 ± 9.4 | 15.9 | ≤0.05 | 0.44 |
N, number of subjects; y, years; SD, standard deviation; Reps, repetitions; ES, effect size; S, one-set; M3 = three-sets; per week, number of days trained per week; LExt, leg extension; RM, repetition maximum; LCurl, leg curl; BC, bicep curl; KExt, knee extension; Con, control group; EExt, elbow extension; SPC, seated preacher curl; EFlex, elbow flexion; SFlex, shoulder flexion; SExt, shoulder extension.
Significantly greater than prior to training (P ≤ 0.05).
Significant differences from corresponding groups-exercise values (P ≤ 0.05).
Significantly greater than prior to training (P ≤ 0.01).
Figure 3Forest plot of 1 vs. 3-sets (trained and untrained subjects [upper body exercise] combined) with Humburg et al. (2007) and Radaelli et al. (2014) datum excluded.
Figure 4Forest plot of 1 vs. 3-sets (untrained and trained subjects [lower body exercise] combined) with Hass et al. (2000) and Humburg et al. (2007) datum excluded.
Figure 5Forest plot of 1 vs. 3-sets (trained and untrained [multi-joint exercise] combined).
Figure 6Forest plot of 1 vs. 3-sets (trained and untrained [single-joint exercises] combined).
Summary of main effects of 1 vs. 3-sets and strength change.
| Trained and untrained combined | 0.93 | 0.41–1.45 | 92 | 0.25 | 0.0005 |
| Untrained subjects only | 1.20 | 0.39–2.01 | 94 | 0.22 | 0.004 |
| Trained subjects only | 0.63 | 0.05–1.22 | 83 | 0.28 | 0.03 |
| Trained and untrained combined | 0.37 | 0.09–0.82 | 68 | 0.19 | 0.11 |
| Untrained subjects only | 0.35 | −0.49–1.19 | 74 | 0.23 | 0.42 |
| Trained subjects only | 0.63 | 0.34–0.92 | 3 | 0.33 | <0.0001 |
| Trained and untrained combined | 0.35 | 0.10–0.60 | 0 | 0.27 | 0.006 |
| Untrained subjects only | 0.49 | 0.14–0.83 | 0 | 0.28 | 0.005 |
| Trained subjects only | 0.18 | −0.23–0.58 | 0 | 0.32 | 0.39 |
| Trained and untrained combined | 0.83 | 0.14–1.51 | 90 | 0.22 | 0.02 |
| Trained subjects only | 0.52 | 0.10–0.94 | 48 | 0.31 | 0.02 |
| Trained and untrained combined | 1.15 | 0.17–2.12 | 92 | 0.24 | 0.02 |
| Trained subjects only | 0.52 | 0.08–0.96 | 34 | 0.32 | 0.02 |
| Trained and untrained combined | 0.09 | −0.32–0.51 | 0 | 0.17 | 0.66 |
| Trained and untrained combined | 0.49 | 0.26–0.72 | 25 | 0.19 | <0.0001 |
| Untrained subjects only | 0.56 | 0.21–0.91 | 41 | 0.23 | 0.002 |
| Trained subjects only | 0.37 | −0.01–0.75 | 23 | 0.09 | 0.06 |
| Trained and untrained combined | 0.20 | −0.07–0.47 | 0 | 0.07 | 0.16 |
| Trained and untrained combined | 0.41 | 0.08–0.74 | 0 | 0.32 | 0.02 |
ES, effect size; 95% CI, 95% confidence level; I;
= statistically different between treatments.